KPV Peptide: The Alpha-MSH Fragment in Inflammation Research
October 27, 2026

KPV is a tripeptide — lysine-proline-valine — that corresponds to the C-terminal fragment of alpha-melanocyte-stimulating hormone (alpha-MSH). It has drawn attention in inflammation research because it appears to retain the anti-inflammatory signaling associated with the parent hormone while shedding the pigmentary activity. That separation of function is what makes it interesting to investigators.
This post covers what KPV is, the research areas where it shows up, and the practical sourcing and quality-control details that matter when you bring it into a lab. Everything here is framed for research use only. KPV sold for laboratory work is not for human consumption, and nothing below should be read as a dosing or administration instruction.
What KPV Is at the Molecular Level
KPV is a short synthetic sequence derived from residues 11–13 of alpha-MSH. Alpha-MSH itself is a 13-amino-acid peptide cleaved from proopiomelanocortin (POMC). The full hormone drives pigmentation through melanocortin receptors, but the C-terminal KPV fragment has been studied as a carrier of the molecule's anti-inflammatory properties without the same melanocortin-1 receptor pigmentary effect.
Because it is only three residues, KPV is small, relatively stable compared with larger peptides, and straightforward to synthesize to high purity by solid-phase methods. Its low molecular weight is one reason it is attractive as a research tool — fewer opportunities for degradation, simpler analytical characterization.
The Mechanistic Hypotheses Under Study
Research literature describes several proposed mechanisms for KPV's activity. The most commonly cited is interference with pro-inflammatory signaling pathways, including modulation of NF-kB activation and downstream cytokine production. Some work has explored receptor-independent effects, suggesting KPV may act intracellularly rather than solely through melanocortin receptors.
Much of the attention has centered on models of intestinal and mucosal inflammation, where KPV has been investigated for its effect on inflammatory markers in epithelial and immune cell systems. These are mechanistic and model findings. They are not evidence of any therapeutic effect in humans, and KPV has no approved human use in Canada.
Research Areas Where KPV Appears
KPV shows up across several lines of preclinical inflammation research:
- Gastrointestinal inflammation models — epithelial barrier and colitis-model systems where cytokine expression and inflammatory signaling are measured.
- Dermatological and wound-related research — cell culture work examining inflammatory responses in skin-derived cells.
- General immunomodulation — studies of macrophage and leukocyte signaling in vitro.
Researchers studying tissue repair sometimes look at KPV alongside other peptides in the same workflow, such as BPC-157, though these are distinct compounds with different proposed mechanisms. If your project spans several related sequences, the full product catalog is a useful starting point for comparing what is available in Canada.
Quality Control: What to Verify Before KPV Enters Your Lab
A short peptide is still only as useful as its characterization. For KPV, the analytical data that genuinely informs experimental design includes:
- HPLC (high-performance liquid chromatography) — the primary purity measure. Research-grade peptides are commonly offered at purity thresholds such as 95%, 98%, or 99%. The HPLC chromatogram on a certificate of analysis (COA) shows the main peak and any detectable impurities.
- Mass spectrometry — confirms molecular identity. For a tripeptide, the expected mass is low and precise, so MS is a strong check that you actually received KPV and not a mislabeled or incorrect sequence.
- Karl Fischer titration — measures residual water content. Peptides are hygroscopic, and water content affects how much actual peptide is in a labeled vial.
- Endotoxin testing — relevant when a COA reports it, particularly for cell-culture work where endotoxin contamination confounds inflammation readouts.
That last point matters more for KPV than for many peptides. If you are measuring cytokine responses, endotoxin contamination can produce a false inflammatory signal. Knowing whether endotoxin data is reported on the COA is worth your attention.
A COA from an independent analytical lab — Janoshik Analytical is one frequently referenced in this space — gives you data you can evaluate yourself rather than taking a vendor's word. Peptide Depot publishes compound-level COAs from Janoshik for some products. Treat any COA as a compound-level report and read the actual values rather than assuming a blanket purity across a catalog.
Storage and Handling
Lyophilized KPV is generally stable when kept cold and dry. Standard practice for research peptides:
- Store lyophilized powder at -20°C for long-term stability; many labs keep working stock at this temperature and note short-term refrigeration (2–8°C) for near-term use.
- Protect from light and moisture. Short peptides are hygroscopic, so minimize freeze-thaw cycles and limit exposure of open vials to humid air.
- Once reconstituted, peptide solutions are less stable than dry powder. Aliquoting to avoid repeated freeze-thaw is common lab practice.
When reconstituting, consistency across experiments is what protects your data. Researchers often use a Peptide Calculator to standardize solution concentrations across runs — this is a concentration tool, not a dosing recommendation.
Common Mistakes When Sourcing KPV for Research
These are the errors that most often cost labs time, money, or data integrity.
- Assuming all "KPV" is the same purity. A 95% and a 99% product are different materials for sensitive assays. Check the actual HPLC figure on the COA, not the marketing headline.
- Ignoring endotoxin status in inflammation work. If you are quantifying inflammatory markers, unreported endotoxin can invalidate results. Ask whether endotoxin data is available.
- Overlooking water content. Karl Fischer data tells you how much of the vial mass is actually peptide. Skipping it introduces concentration error into every downstream calculation.
- Not confirming identity by mass spectrometry. For a three-residue peptide, MS confirmation is quick and decisive. Use it.
- Treating a single COA as proof of every vial you'll ever receive. A compound-level COA characterizes a reference sample. It is useful data, but understand what it does and does not cover before you build conclusions on it.
- Poor documentation. Record lot information, storage conditions, and reconstitution details in your lab notebook. Reproducibility depends on it.
If you want to compare analytical documentation and sourcing practices generally, the Peptide Depot FAQ covers how the supplier handles product information. KPV is also listed directly on its product page for Canadian researchers.
Why Canadian Labs Care About Domestic Supply
Sourcing within Canada reduces customs delays and the temperature exposure that comes with long international transit — a real concern for peptides that should stay cold and dry. A Canadian supplier like Peptide Depot shortens that chain. Shorter transit means less risk to a cold-sensitive, hygroscopic compound before it reaches your freezer.
Regardless of source, the labeling standard is the same: research-use-only material is not for human consumption and is not supplied for in vivo or animal use.
Frequently Asked Questions
What is KPV peptide?
KPV is a tripeptide (lysine-proline-valine) that corresponds to the C-terminal fragment of alpha-melanocyte-stimulating hormone (alpha-MSH). It is studied in inflammation research for anti-inflammatory signaling properties associated with the parent hormone, without the same pigmentary activity.
Is KPV the same as alpha-MSH?
No. Alpha-MSH is a full 13-amino-acid hormone, while KPV is a three-residue fragment derived from its C-terminus. KPV has been studied as a carrier of alpha-MSH's anti-inflammatory signaling while lacking the full hormone's pigmentary effects.
What quality control data should I look for on a KPV COA?
Look for HPLC for purity (often reported at 95%, 98%, or 99%), mass spectrometry to confirm identity, Karl Fischer titration for water content, and endotoxin data where reported. Endotoxin information is especially relevant for inflammation assays, where contamination can produce misleading signals.
How should KPV be stored in a research setting?
Lyophilized KPV is typically stored at -20°C for long-term stability and kept away from light and moisture. Reconstituted solutions are less stable than dry powder, so labs commonly aliquot to reduce freeze-thaw cycles.
Is KPV approved for human use in Canada?
No. KPV supplied for laboratory work is a research-use-only compound and is not for human consumption. It has no approved human use and is not supplied for in vivo or animal applications.
This article is for educational purposes and describes KPV as a research compound only. Products referenced are for laboratory research use and are not for human consumption.